GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BUD:BAYER) » Definitions » Change In Receivables

Bayer AG (BUD:BAYER) Change In Receivables : Ft75,474 Mil (TTM As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Bayer AG Change In Receivables?

Bayer AG's change in receivables for the quarter that ended in Dec. 2024 was Ft574,944 Mil. It means Bayer AG's Accounts Receivable declined by Ft574,944 Mil from Sep. 2024 to Dec. 2024 .

Bayer AG's change in receivables for the fiscal year that ended in Dec. 2024 was Ft74,077 Mil. It means Bayer AG's Accounts Receivable declined by Ft74,077 Mil from Dec. 2023 to Dec. 2024 .

Bayer AG's Accounts Receivable for the quarter that ended in Dec. 2024 was Ft3,371,451 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Bayer AG's Days Sales Outstanding for the three months ended in Dec. 2024 was 69.75.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bayer AG's liquidation value for the three months ended in Dec. 2024 was Ft-21,543,292 Mil.


Bayer AG Change In Receivables Historical Data

The historical data trend for Bayer AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Change In Receivables Chart

Bayer AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 303,622.85 -24,751.87 102,329.71 269,818.27 74,077.16

Bayer AG Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 383,384.74 -1,877,104.33 262,854.04 1,114,779.92 574,944.04

Bayer AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Ft75,474 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bayer AG  (BUD:BAYER) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bayer AG's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3371450.787/4410411.14*91
=69.75

2. In Ben Graham's calculation of liquidation value, Bayer AG's accounts receivable are only considered to be worth 75% of book value:

Bayer AG's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=3040923.769-29632743.618+0.75 * 3371450.787+0.5 * 5039878.976
=-21,543,292

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bayer AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bayer AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG Business Description

Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm's crop science business sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.

Bayer AG Headlines

No Headlines